Phenoxybenzamine recalls

The FDA has published 2 recalls involving Phenoxybenzamine since 2022. The latest was reported on 14 Feb 2024. Most were for potency & assay. Amneal Pharmaceuticals of New York has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2022

Last 12 months0reported

Class I00% of total

Ongoing0latest 14 Feb 2024

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why phenoxybenzamine is recalled

Potency & Assay2100%

Companies

By year

2024150%
2022150%

All phenoxybenzamine recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
14 Feb 2024Drug	CLASS II	Phenoxybenzamine Hydrochloride Capsules, USP 10mg recalled	Amneal Pharmaceuticals of New York	Potency & Assay	Nationwide
23 Nov 2022Drug	CLASS II	Phenoxybenzamine Hydrochloride Capsules, USP 10mg recalled	Par Formulations Private	Potency & Assay	Nationwide

Should you stop taking Phenoxybenzamine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.